
Agilent Technologies (A) Stock Forecast & Price Target
Agilent Technologies (A) Analyst Ratings
Bulls say
Agilent Technologies is a leading life science and diagnostic firm that is benefiting from stable and profitable end markets in biopharmaceutical, chemical, and advanced materials. With a geographically diverse business and strong operational execution, Agilent is well-positioned for continued growth in the future. The company's focus on sustainability and strategic acquisitions adds to its long-term outlook.
Bears say
Agilent Technologies is facing several challenges that could negatively impact its stock price, including tougher sales comparisons in its high-growth pharmaceutical and biotech end markets, and potential disappointment in margin expansion. Additionally, the company's exposure to China and its ongoing trade tensions could also pose a risk to its growth algorithm. Furthermore, while Agilent has a diverse and geographically diversified business, it remains vulnerable to softness in academic and government demand, as well as potential headwinds in its diagnostics business segment.
This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.
Agilent Technologies (A) Analyst Forecast & Price Prediction
Start investing in Agilent Technologies (A)
Order type
Buy in
Order amount
Est. shares
0 shares